While it has been postulated that FOXP3+ Tregs may induce immune suppression within the TME and consequently exacerbate GC prognosis, the meta-analysis revealed that FOXP3+ Treg infiltration did not exhibit a definitive association with clinical outcomes. Here, FOXP3 is linked to gastric cancer.